Medprime Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.86 M
as on 16-11-2024
- Company Age 10 Year, 28 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 16-11-2024
- Revenue 142.52%
(FY 2023)
- Profit 21.10%
(FY 2023)
- Ebitda 24.15%
(FY 2023)
- Net Worth 0.55%
(FY 2023)
- Total Assets -18.42%
(FY 2023)
About Medprime Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.86 M.
The company currently has active open charges totaling ₹1.50 M.
Binil Jacob, Mahesh Rathor, Samrat, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120MH2014PTC259735
- Company No.
259735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medprime Technologies Private Limited offer?
Medprime Technologies Private Limited offers a wide range of products and services, including Microscope, Digital Microscope, Optical Microscope, Fluorescent Microscope, Binocular Microscope, Metallurgical & Lab Microscopes, Laboratory Microscope, Biological Microscope, Medical Microscope, Tissue Culture Microscope.
Who are the key members and board of directors at Medprime Technologies?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samrat  | Director | 26-Nov-2014 | Current |
| Mahesh Rathor | Director | 26-Nov-2014 | Current |
| Greeshma Unnikrishnan | Director | 26-Nov-2014 | Current |
| Binil Jacob | Director | 26-Nov-2014 | Current |
Financial Performance of Medprime Technologies.
Medprime Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 142.52% increase. The company also saw a substantial improvement in profitability, with a 21.1% increase in profit. The company's net worth moved up by a moderate rise of 0.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medprime Technologies?
In 2023, Medprime Technologies had a promoter holding of 87.74% and a public holding of 12.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 22 Oct 2019 | ₹1.50 M | Open |
How Many Employees Work at Medprime Technologies?
Medprime Technologies has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medprime Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medprime Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
